Fluoretiq Limited

In this project, we will be working with experts at the National Physical Laboratory (NPL), Newton Gateway to Mathematics, Science and Technology Facilities Council (STFC) to investigate the source and mechanism of interference of known contaminants within commercially available reagents. The project will utilise a combination of state of the art spectros...

Over 250 million antibiotic prescriptions are issued annually; nearly half are done blindly. Incorrect prescriptions lead to drug resistant infections, which kill 1.2 million people annually and will kill more people than cancer by 2050\. FluoretiQ's mission is to provide clinicians with rapid tests to make their first antibiotic prescription, the right p...

Brain tumours reduce the life expectancy for an average patient by 20 years. In the UK in 2013: 38 % of brain tumour patients visited their GP 5 times or more, typically over 15 weeks, before diagnosis because symptoms such as headache are non-specific. Although headaches are strongly associated with brain cancer, the chance of a patient with headache hav...

This project aims to deliver a fast and accurate disposable test for diagnosing bacterial infections. The aim will be achieved through secondment of Dr. Pugh, Senior Research Associate and microfluidics expert at University of Bristol to medtech start-up FluoretiQ. Dr. Pugh will gain key assay development and commercial decision making skills which will e...

According to a recent survey of 532 veterinary surgeries by the Royal College of Veterinary Surgeons, 99% had noticeable reductions in weekly turnover, with 66% reporting reductions of 51% or more, as a result of social distancing measures implemented during the covid-19 pandemic. 451 of the 532 veterinary surgeries also reported that they had now moved t...

This project aims to address the need for rapid tools for detecting bacteria in patient samples. FluoretiQ Limited and the University of Bristol, will develop a new quantum-optics enhanced bacteria diagnostic solution which utilises novel, non-toxic labelling technology to detect bacteria directly, at the point of care. Unlike currently proposed alternati...